Shigeaki Sunada

CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity

Shigeaki Sunada, Hiroko Saito, Doudou Zhang et al. · Biochemical and Biophysical Research Communications · 2021 · 105 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation

Hiroshi Fujisawa, Nakako Izumi Nakajima, Shigeaki Sunada et al. · Radiation Oncology · 2015 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +16

Nontoxic concentration of <scp>DNA</scp>‐<scp>PK</scp> inhibitor NU7441 radio‐sensitizes lung tumor cells with little effect on double strand break repair

Shigeaki Sunada, H. Kanai, Younghyun Lee et al. · Cancer Science · 2016 · 36 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining

Younghyun Lee, Huizi Keiko Li, Aya Masaoka et al. · Radiotherapy and Oncology · 2016 · 32 citations · Full text

Medicine, Molecular Biology, Oncology +17

Monoglucosyl-rutin as a potential radioprotector in mammalian cells

Shigeaki Sunada, Hiroshi Fujisawa, Ian M. Cartwright et al. · Molecular Medicine Reports · 2014 · 30 citations · Full text

Medicine, Radiation Oncology, Dna Repair +16